E2F1 and glioblastoma: Dual-Luciferase reporter assays demonstrated miR-1258 directly binding to E2F1 3’-UTR, thereby inhibiting E2F1 expression, consistent with our results that E2F1 expressed highly in GBM tissues as well as GBM cell lines.